Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Deciphera starts Phase Ib/II trial of Rebastinib and Paclitaxel

Endometrial cancer is the most commonly diagnosed gynecological cancer. Credit: Darryl Leja, NHGRI.



  • Endometrial cancer

Go Top